FDA Inspection 1266119 — Akeso-Sino Pharma Co., Ltd.
The FDA completed an inspection of Akeso-Sino Pharma Co., Ltd. on Mar 7, 2025 in Zhongshan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 7, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zhongshan (China)
Additional details
Sponsor, Contract Research Organization